A combination of 60 mg/m2 cisplatin (CDDP) and 200 mg/m2 carboplatin (CBDCA) is as active but less nephrotoxic than 120 mg/m2 CDDP in patients with advanced non-small cell lung cancer (NSCLC)
Title:
A combination of 60 mg/m2 cisplatin (CDDP) and 200 mg/m2 carboplatin (CBDCA) is as active but less nephrotoxic than 120 mg/m2 CDDP in patients with advanced non-small cell lung cancer (NSCLC)
Author:
Giner, V. Sculier, J.P. Klastersky, J. Bureau, G. Thiriaux, J. Efremidis, A. Berchier, Mc. Kroll, F. Ries, F. Mommen, P. Paesmans, M.